Bengaluru Healthcare Startup’s Zero-Wait, Zero-Commission Hospital Model Draws Interest from Veteran Investor as It Plans National Expansion
Healthcare startup Superhealth is in discussions to raise about $10 million from entrepreneur and investor Ronnie Screwvala, founder of UpGrad, according to people familiar with the matter. The proposed investment would support the Bengaluru-based company’s plans to scale its distinctive hospital network built around salaried doctors, fixed pricing and a promise of zero wait times and zero commissions.
The Proposed Round
The talks are at an advanced stage, though the final structure, valuation and exact allocation between equity and other instruments have not been publicly confirmed. Screwvala has in recent years expanded his personal investment activity beyond education into consumer and technology-enabled businesses, and Superhealth’s model appears to align with his interest in scalable, consumer-facing platforms that challenge traditional industry structures.
Superhealth has not issued an official comment on the fundraising discussions.
Superhealth’s Model
Founded by Varun Dubey, a former Chief Revenue Officer at Apollo Hospitals and earlier associated with Practo and Ola Electric, Superhealth positions itself as India’s first zero-wait, zero-commission hospital network. The company operates a flagship 50-bed facility in Koramangala, Bengaluru, and follows an asset-light approach that keeps capital expenditure per bed significantly lower than that of traditional corporate hospitals.
Doctors are employed on fixed salaries rather than being remunerated through procedure-linked commissions. Surgical and treatment prices are standardised. The company claims this structure reduces incentives for unnecessary procedures and improves trust. It also offers a “VIP pass” priced at ₹3,999 per year covering four family members for unlimited consultations and specified diagnostics.
Co-founders include Dr Alexander Kuruvilla, who has held senior roles at Apollo and Narayana Health, and Manoj Kumar, a former Practo executive. The company recently appointed Dalvir Suri, former co-founder of Dunzo, to lead operations as it prepares to replicate the model across multiple locations.
Earlier Funding and Backers
Prior to the current discussions, Superhealth had raised around ₹17 crore from angel investors and secured ₹50–55 crore through debt and infrastructure financing. Early backers include Sparrow Capital, Natasha M. Oswal, Endurance Technologies founder Anurang Jain, and the family office of former cricketer MS Dhoni. The company has also been in broader fundraising conversations, with reports earlier this year of a larger blended equity-and-debt round of around ₹100 crore to support expansion in Bengaluru.
Expansion Plans
Superhealth aims to add several more hospitals in Bengaluru in the near term and ultimately build a network of 100 hospitals across India over the next five to seven years. The long-term vision includes thousands of beds and significant job creation in the healthcare sector. The company uses technology, including AI-enabled clinical and operational workflows, to improve efficiency, reduce paperwork and shorten average length of stay.
Why the Deal Matters
A cheque from Ronnie Screwvala would add a high-profile name to Superhealth’s cap table and provide both capital and credibility as the startup seeks to scale a model that challenges conventional hospital economics. For Screwvala, it would represent a bet on a consumer healthcare platform that emphasises transparency and cost efficiency — themes that have also featured in his education-sector ventures.
India’s healthcare market continues to expand, driven by rising incomes, insurance penetration and demand for quality care outside the largest metro hospitals. Startups that can combine lower capital intensity with a differentiated patient experience are attracting investor attention, even as the sector remains operationally complex and highly regulated.
Outlook
If the $10 million investment materialises, it would give Superhealth additional firepower to accelerate hospital additions, strengthen technology systems and hire talent for multi-city operations. Execution risk remains high: replicating a single successful facility across dozens of locations while maintaining clinical quality and cost discipline will be the key test.
Investors and industry observers will watch whether Superhealth can convert its early traction in Bengaluru into a nationally relevant hospital brand. For now, the talks with Screwvala underscore growing interest in alternative hospital models that promise greater transparency and lower costs for patients.
